Antigenics Raising $31.6M Via Stock Sale To Single Investor Sep. 22, 2003 By Aaron Lorenzo and Brady Huggett No Comments
454 Life Sciences Secures $20M To Begin Commercial Operations Sep. 19, 2003 By Aaron Lorenzo No Comments
454 Life Sciences Secures $20M To Begin Commercial Operations Sep. 19, 2003 By Aaron Lorenzo No Comments
Stressgen Drug Hits Endpoint In Prolonging Surgery Interval Sep. 17, 2003 By Aaron Lorenzo No Comments
Stressgen Drug Hits Endpoint In Prolonging Surgery Interval Sep. 17, 2003 By Aaron Lorenzo No Comments
Paratek Pairs Lead Anti-Infective With Bayer As Clinical Trials Near Sep. 16, 2003 By Aaron Lorenzo No Comments
Paratek Pairs Lead Anti-Infective With Bayer As Clinical Trials Near Sep. 16, 2003 By Aaron Lorenzo No Comments
Ligand Gains $47M In Private Sale To Expand Commercial Activities Sep. 15, 2003 By Aaron Lorenzo No Comments
Ligand Gains $47M In Private Sale To Expand Commercial Activities Sep. 15, 2003 By Aaron Lorenzo No Comments
XOMA Plans Public Offering Of 9M Shares Following Panel Nod Sep. 12, 2003 By Aaron Lorenzo No Comments Two days after an FDA advisory panel recommended approval of its partnered psoriasis drug Raptiva, XOMA Ltd. disclosed plans for a public offering of 9 million common shares. (BioWorld Today)Read More
